Jefferson University Hospitals


Related Content

Retinoblastoma is the most common primary intraocular malignancy of childhood, occurring in approximately 1 in 16,000 live births in the United States and Northern Europe. Retinablostoma can be familial or sporadic and approximately 95 percent of children with retinoblastoma present before the age of five. 

Preventing the loss of life, vision, or eye of the child is optimal if a diagnosis of retinoblastoma is discovered. Jefferson Hospital for Neuroscience is home to one of the most advanced treatment centers in the country for this rare and potentially lethal cancer. 

Working in partnership with Wills Eye Hospital, our physicians are currently using intraparterial chemotherapy to treat retinoblastoma and are one of the only two programs in the United States aimed at treating this rare ophthalmic tumor.

Wills Eyes sees 50 percent of all the cases in the country and our results have shown the ability to preserve the eye, and in many cases the patient's vision, since the programs inception.

Make an Appointment

Call 1-800-JEFF-NOW (1-800-533-3669) to make an appointment with a Jefferson Health specialist.